Torsdag 26 December | 12:05:13 Europe / Stockholm

Kalender

Tid*
2026-01-10 N/A Årsstämma
2025-11-30 N/A Bokslutskommuniké 2025
2025-07-17 08:30 Kvartalsrapport 2025-Q3
2025-04-17 08:30 Kvartalsrapport 2025-Q2
2025-02-19 08:30 Kvartalsrapport 2025-Q1
2025-02-03 N/A X-dag ordinarie utdelning CSMED 0.00 DKK
2025-01-31 N/A Årsstämma
2024-11-30 - Bokslutskommuniké 2024
2024-11-12 - Extra Bolagsstämma 2024
2024-08-15 - Kvartalsrapport 2024-Q3
2024-05-30 - Årsstämma
2024-05-17 - Kvartalsrapport 2024-Q2
2024-03-01 - X-dag ordinarie utdelning CSMED 0.00 DKK
2024-02-14 - Bokslutskommuniké 2023
2024-02-14 - Kvartalsrapport 2024-Q1
2023-12-15 - X-dag ordinarie utdelning CSMED 0.00 DKK
2023-07-18 - Kvartalsrapport 2023-Q3
2023-05-17 - Kvartalsrapport 2023-Q2
2023-04-14 - Extra Bolagsstämma 2023
2023-02-17 - Kvartalsrapport 2023-Q1
2023-02-14 - Årsstämma
2023-02-10 - X-dag ordinarie utdelning CSMED 0.00 DKK
2022-11-18 - Bokslutskommuniké 2022
2022-08-13 - Kvartalsrapport 2022-Q3
2022-05-20 - Kvartalsrapport 2022-Q2
2022-02-18 - Kvartalsrapport 2022-Q1
2021-12-10 - X-dag ordinarie utdelning CSMED 0.00 DKK
2021-12-09 - Årsstämma
2021-11-18 - Bokslutskommuniké 2021

Beskrivning

LandDanmark
ListaSpotlight DK
SektorHälsovård
IndustriLäkemedel & Handel
CS Medica är ett danskt medicintekniskt bolag, dedikerat till läkemedelsforskning, utveckling, tillverkning och global kommersialisering. Bolaget blandar vetenskap och natur för att förbättra patienters liv med cannabinoidterapier för smärtlindring, och för att hantera autoimmuna och stressrelaterade symtom. Globalt erbjuder CS Medica CBD-behandlingar över disk (OTC), inklusive patenterade medicinska produkter, MHRA och MDR-registrerade artiklar, under varumärket CANNASEN® eller med egen märkning.
2022-04-06 13:31:59

CS MEDICA A/S (" CS MEDICA" or the" Company") announces today that as of May 1, 2022 Heidi Ahlefeldt-Laurvig will take over as Chief Growth Officer (CGO) and Chief Marketing Officer (CMO).

CS MEDICA has appointed Heidi Ahlefeldt-Laurvig as the new Chief Marketing & Growth Officer. Heidi has more than 15 years of experience delivering profitable growth and building brands. With a successful track record in marketing and digital transformation, Heidi works seamlessly in an organization due to her different roles within sales, brand management, and marketing, retail, and e-commerce which will match the team and high growth expectations for CS MEDICA.

Most recently Heidi comes from a position as Chief Commercial Officer responsible for Marketing & E-commerce for Life Extension Europe, an e-commerce company distributing premium brands within vitamins & supplements to over 30 countries. In her role, she helped transform and grow the Company from a product-driven webshop to a data-driven e-commerce platform with multiple strong brands. Companies Heidi also has experience from are amongst others, Dagrofa/MENY, Coop/Kvickly, Cloetta, L'Oréal, Gillette/P&G, and YouSee.

Heidi brings relevant and significant experience to help boost growth and launch plans to bring CS MEDICA's products onto new markets and platforms. As the new CGO/CMO, Heidi will lead, manage, and develop the companies' two subsidiaries' branding, marketing, and communication. Additionally, she will focus on growing an agile, digital marketing team and onboarding CanNordic's products on Amazon in Europe and, subsequently, the USA and Canada in collaboration with international partners.

Comment from Lone Henriksen:
"I am happy to welcome Heidi Ahlefeldt-Laurvig as CGO/CMO. Heidi has extensive experience in marketing and digitalization and possesses a rare toolbox encompassing a complete set of skills corresponding to our ambitions. With Heidi's expertise, I am confident that she will be an important asset in our continued growth journey." 

Heide will take on the role of CGO/CMO on May 1, 2022.